Wave Life Sciences Ltd. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Wave Life Sciences Ltd. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q1 2024.
  • Wave Life Sciences Ltd. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $2.88M, a 4.76% increase year-over-year.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2024 was $13.1M, a 34.2% increase from 2023.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $9.8M, a 43% decline from 2022.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2022 was $17.2M, a 4.8% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.